Abstract
In this report, three cases of sclerosing encapsulating peritonitis (SEP) are described; two of them were associated with pleural and/or pericardial effusions.
Similar content being viewed by others
References
Dobbie, J. W.: Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis.Perit. Dial. Int., 12, 1 (1992).
Gandhi, V. C., Humayun, H. M., Ing, T. S., Daugirdas, J. T., Jabolov, V. R., Iwatsuki, S., Geis, P., Hano, J. E.: Sclerotic thickening of the peritoneum membrane in maintenance peritoneal dialysis patients.Arch. Intern. Med. 140, 1201 (1980).
Gandhi, V. C., Ing, T. S., Daugirdas, J. T., Hagen, C., Blumenkrantz, M. J., Jabolov, V. R.: Fallure of peritoneal dialysis due to peritoneal sclerosis.Int. J. Artif. Organs, 6, 97 (1983).
Harty, R. F.: Sclerosing peritonitis and propranolol.Arch. Intern. Med., 138, 1424 (1978).
Junor, B. J. R., Briggs, J. D., Forwell, M. A.: Sclerosing peritonitis—the contribution of chlorhexidine in alcohol.Perit. Dial. Bull., 5, 101 (1985).
Marigold, J. H., Pounder, R. E., Pemberton, J., Thompson, R. P. H.: Propranolol, oxyprenolol and sclerosing peritonitis.Br. Med. J., 1, 870 (1982).
Oreopoulos, D. G., Khanna, R., Wu, G.: Sclerosing obstructive peritonitis after CAPD.Lancet, 2, 409 (1983).
Rottenburg, J., Issad, B., Langlois, P., De Groc, F., Legrain, M.: Sclerosing encapsulating peritonitis during CAPD. Evaluation of the potential risk factors. In: Maher, J. F., Winchester, J. F. (eds): Frontiers in Peritoneal Dialysis. Field, Rich and Associates, Inc., New York 1986, p. 643.
Rottenburg, J., Gahl, G. M., Poignet, J. L., Mertani, E., Strippoli, P., Langlois, P., Tranbaloc, P., Legrain, M.: Severe abdominal complications in patients undergoing continuous peritoneal dialysis.Proc. Eur. Dial. Transplant. Assoc., 20, 236 (1983).
Ruiz, P. G., Medina, A. V., Roldan, C. G., Von Hunefeld, M. F., Sanchez, T. A.: Sclerosing peritonitis associated with pleural and pericardial effusions.Perit. Dial. Int., 8, 217 (1988).
Schmidt, R. W., Blumenkrantz, M.: Peritoneal sclerosis: A “Sword of Damocles” for peritoneal dialysis?Arch. Intern. Med., 141, 1265 (1980).
Shaldon, S., Koch, K. M., Quellhorst, E.: Pathogenesis of sclerosing peritonitis in CAPD.Trans. Am. Soc. Artif. Intern. Organs, 30, 193 (1984).
Slingeneyer, A., Canaud, B., Mion, C.: Permanent loss of ultrafiltration capacity of the peritoneum in long term peritoneal dialysis: An epidemiological study.Nephron, 33, 133 (1983).
Verger, C., Brunschvig, O., Le Charpentier, Y., Lavergne, A., Vantelon, J.: Structural and ultrastructural peritoneal membrane changes and permeability alterations during CAPD.Proc. Eur. Dial. Transplant. Assoc., 18, 199 (1981).
Wanic-Kossowska, M., Grzegorzewska, A.: Sclerosing peritonitis in a patient treated with intermittent peritoneal dialyses.Przeg. Lek., 47, 291 (1990).
Mc Whinnie, D. L., Bradley, J. A., Bramwell, S. P., Hamilton, D. N. H., Macpherson, S. G., Cram, L. P., More, I. A. R., Forwell, M. A., Smith, W. G. H., Briggs, J. D., Junor, B. J. R.: Sclerosing peritonitis—a further complication of CAPD. In: Maher, J. F. Winchester, J. F. (eds.): Frontiers in Peritoneal Dialysis. Field, Rich and Associates, Inc., New York 1986, p. 638.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wanic-Kossowska, M., Grzegorzewska, A. & Płotast, H. Sclerosing encapsulating peritonitis. International Urology and Nephrology 30, 223–227 (1998). https://doi.org/10.1007/BF02550581
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02550581